Literature DB >> 28150518

Chloroquine attenuates TLR3/IFN-β signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritis.

Tadaatsu Imaizumi1, Ryo Hayakari1, Tomoh Matsumiya1, Hidemi Yoshida1, Kazushi Tsuruga2, Shojiro Watanabe2, Shogo Kawaguchi3, Hiroshi Tanaka1,4.   

Abstract

BACKGROUND: Chloroquine has been reported to protect against renal damage in lupus nephritis (LN); however, its detailed mechanism in glomerular inflammation remains unclear. Upregulation of the type-I interferon (IFN) system plays a pivotal role in LN pathogenesis, therefore, we examined whether chloroquine inhibits toll-like receptor 3 (TLR3)/IFN-β signaling in cultured normal human mesangial cells (MCs).
METHODS: We examined chloroquine effect on the representative TLR3/IFN-β-signaling axis, TLR3/IFN-β/retinoic acid-inducible gene-I (RIG-I)/CCL5 in MCs treated with polyinosinic-polycytidylic acid (poly IC), a synthetic viral dsRNA analog and analyzed the expression of these molecules using reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA). Furthermore, we subjected MCs to RNA interference against NF-κB p65.
RESULTS: Pretreatment of cells with chloroquine attenuated IFN-β, RIG-I and CCL5 expression and phosphorylation of STAT1 induced by poly IC, but not IFN-β-induced phosphorylation of STAT1 and RIG-I expression induced by IFN-β. Knockdown of p65 inhibited the poly IC-induced IFN-β expression, and chloroquine pretreatment decreased the nuclear poly IC-induced translocation of NF-κB p65 in MCs.
CONCLUSION: These results suggest that chloroquine attenuates mesangial TLR3 signaling in the early phase of NF-κB activation. Considering that TLRs/type-I IFNs signaling is implicated in LN pathogenesis, our results may further support regional renoprotective effects of chloroquine in treating LN.

Entities:  

Keywords:  Chloroquine; NF-κB; TLR3; lupus nephritis; mesangial cells

Mesh:

Substances:

Year:  2017        PMID: 28150518     DOI: 10.1080/14397595.2017.1289646

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

Review 1.  Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.

Authors:  Hiroshi Tanaka; Kensuke Joh; Tadaatsu Imaizumi
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

Review 2.  Mesangial Cells in Lupus Nephritis.

Authors:  Tamara K Nowling
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

3.  Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells.

Authors:  Riko Sato; Tadaatsu Imaizumi; Tomomi Aizawa; Shojiro Watanabe; Koji Tsugawa; Shogo Kawaguchi; Kazuhiko Seya; Tomoh Matsumiya; Hiroshi Tanaka
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 4.  Toll-like receptors in lupus nephritis.

Authors:  Satish Kumar Devarapu; Hans-Joachim Anders
Journal:  J Biomed Sci       Date:  2018-04-12       Impact factor: 8.410

Review 5.  Hydroxychloroquine in rheumatic autoimmune disorders and beyond.

Authors:  Eliise Laura Nirk; Fulvio Reggiori; Mario Mauthe
Journal:  EMBO Mol Med       Date:  2020-07-26       Impact factor: 12.137

Review 6.  Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?

Authors:  Jayakanthan Kabeerdoss; Debashish Danda
Journal:  Int J Rheum Dis       Date:  2020-08-10       Impact factor: 2.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.